Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Deferred Revenue: 2012-2024

Historic Current Deferred Revenue for Veracyte (VCYT) over the last 10 years, with Dec 2024 value amounting to $1.7 million.

  • Veracyte's Current Deferred Revenue fell 79.49% to $417,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $417,000, marking a year-over-year decrease of 79.49%. This contributed to the annual value of $1.7 million for FY2024, which is 16.68% down from last year.
  • Latest data reveals that Veracyte reported Current Deferred Revenue of $1.7 million as of FY2024, which was down 16.68% from $2.0 million recorded in FY2023.
  • Veracyte's 5-year Current Deferred Revenue high stood at $4.6 million for FY2021, and its period low was $371,000 during FY2020.
  • Over the past 3 years, Veracyte's median Current Deferred Revenue value was $2.0 million (recorded in 2023), while the average stood at $2.1 million.
  • As far as peak fluctuations go, Veracyte's Current Deferred Revenue spiked by 1,152.29% in 2021, and later tumbled by 43.76% in 2022.
  • Over the past 5 years, Veracyte's Current Deferred Revenue (Yearly) stood at $371,000 in 2020, then soared by 1,152.29% to $4.6 million in 2021, then plummeted by 43.76% to $2.6 million in 2022, then fell by 23.15% to $2.0 million in 2023, then fell by 16.68% to $1.7 million in 2024.